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Abstract
Cellular and viral S-adenosylmethionine-dependent methyltransferases are involved in many regulated processes such as
metabolism, detoxification, signal transduction, chromatin remodeling, nucleic acid processing, and mRNA capping. The
Severe Acute Respiratory Syndrome coronavirus nsp16 protein is a S-adenosylmethionine-dependent (nucleoside-29-O)-
methyltransferase only active in the presence of its activating partner nsp10. We report the nsp10/nsp16 complex structure
at 2.0 A ˚ resolution, which shows nsp10 bound to nsp16 through a ,930 A ˚2 surface area in nsp10. Functional assays identify
key residues involved in nsp10/nsp16 association, and in RNA binding or catalysis, the latter likely through a SN2-like
mechanism. We present two other crystal structures, the inhibitor Sinefungin bound in the S-adenosylmethionine binding
pocket and the tighter complex nsp10(Y96F)/nsp16, providing the first structural insight into the regulation of RNA capping
enzymes in (+)RNA viruses.
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Introduction
Most eukaryotic cellular and viral mRNAs are modified by the
addition of a polyadenine tail at the 39- terminal and a cap
structure at the 59-terminal. The RNA cap protects mRNA from
degradation by 59 exoribonucleases, ensures efficient mRNA
translation, and prevents recognition of viral RNA via innate
immunity mechanisms[1,2,3,4]. The RNA cap is made of an N7-
methylated guanine nucleotide connected through a 59-59
triphosphate bridge to the first transcribed nucleotide, generally
an adenine. Through 29-O methylation of the latter, this cap-0
structure (
7MeGpppA…) may be converted into a cap-1 structure
(
7MeGpppA29-O-Me…). In the eukaryotic cell, the cap is added co-
transcriptionally in the nucleus by three sequential enzymatic
reactions[1,5]: (i) an RNA triphosphatase (RTPase) removes the 59
c-phosphate group of the nascent mRNA; (ii) a guanylyltransferase
(GTase), dubbed capping enzyme, catalyses the attachment of
GMP to the 59-diphosphate mRNA; and (iii) an S-adenosylme-
thionine (SAM)-dependent (N7-guanine)-methyltransferase
(N7MTase) methylates the cap onto the N7-guanine, releasing
S-adenosylhomocysteine (SAH). In general, a SAM-dependent
(nucleoside-29-O-)-methyltransferase (29-O-MTase) further inter-
venes, in higher eukaryotes, to yield a cap-1 structure.
The viral RNA capping machinery is structurally and
mechanistically diverse, and RNA viruses often deviate from the
paradigmic eukaryotic mRNA capping scheme. For example,
alphaviruses methylate GTP onto the N7-guanine before the
presumed attachment of
7MeGMP to the nascent viral 59-
diphosphate mRNA[6]. In the case of single-stranded negative-
sense (-)RNA viruses, such as the vesicular stomatitis virus, the L
polymerase attaches GDP rather than GMP to a nascent viral 59-
monophosphate mRNA, covalently linked to the viral capping
enzyme[7]. Other viruses, such as influenza virus capture a short
capped RNA oligonucleotide from host cell mRNAs and use it as
an RNA synthesis primer. This process is known as « cap
snatching »[8].
In 2003, a novel coronavirus named Severe Acute Respiratory
Syndrome coronavirus (SARS-CoV[9]) was responsible for the first
viral pandemic of the new millennium with ,8000 cases globally
and a 10 % case-fatality rate. Coronaviruses encode an unusually
large membrane-associated RNA replication/transcription machin-
ery comprising at least sixteen proteins (nsp1-to-16)[10]. For
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type[11,12,13]. As in many other (+)RNA viruses, the RTPase
activity is presumably embedded in the RNA helicase nsp13,
whereas the GTase remains elusive. RNA cap 29-O-MTase activity
was first discovered in the feline coronavirus (FCoV) nsp16[14].
Shortly after, SARS-CoV nsp14 was shown to methylate RNA caps
in their N7-guanine position[15]. Curiously, although closely
homologous to that of FCoV, recombinant SARS-CoV nsp16
alone was devoid of enzymatic activity. It was demonstrat-
ed[16,17,18,19] that nsp10 interacts with nsp16, conferring 29-O-
MTase activity to nsp16 on N7-methyl guanine RNA caps
selectively[16]. The latter selectivity implies that RNA cap
methylation obeys an ordered sequence of events during which
nsp14-mediated N7-guanine methylation precedes nsp10/nsp16
RNA29-O methylation.Nsp10isa doublezincfingerproteinof148
residues whose crystal structure is known[20,21]. Together with
nsp4, nsp5, nsp12, nsp14, and nsp16, nsp10 has been found to be
essential in the assembly of a functional replication/transcription
complex[22]. Drawing on these observations, nsp10 has been
proposed to play pleiotropic roles in viral RNA synthesis[23] and
polyprotein processing through interaction with the main protease
nsp5[24].
SAM-dependent MTases belong to a large class of enzymes
present in all life forms. These enzymes catalyze the transfer of the
SAM methyl group to a wide spectrum of methyl acceptors,
indicating that a common chemical reaction is used on a variable
active-site environment able to activate the methyl acceptor atom.
Although SAM-dependent MTases share little sequence identity,
29O-MTases exhibit a KDKE catalytic tetrad and a very
conserved folding made of a seven-stranded b-sheet surrounded
by one to three helices on each side[25], always similar to the
paradigmatic catechol-O-MTase[26]. The SAM binding site
general location is conserved, suggesting that evolutionary pressure
on the MTase fold has maintained the same SAM-binding region
whilst accommodating the versatile chemistry of the methyltrans-
fer reaction.
Structural and functional studies of viral MTases involved in
RNA capping is an expanding research area, since these enzymes
show unexpected diversity relative to their cellular counterparts,
and thus constitute attractive antiviral targets. Crystal structures of
viral RNA cap MTases exist for only three viral families, namely
Poxviridae, Reoviridae, and Flaviviridae. The Vaccinia virus VP39
crystal structure was the first to be elucidated in 1996[27]. The
structure of this DNA virus RNA 29-O-MTase revealed a
conserved MTase fold similar to that of RrmJ (also named FtsJ),
the canonical reference folding for RNA cap MTases[26]. More
recently, the crystal structure of a second Vaccinia virus N7-
guanine RNA cap MTase domain (D1) was determined in
complex with its activator protein D12[28]. The study revealed
that D12 also bears an MTase fold, but has lost catalytic capability
due to truncation of its SAM binding site. In turn, Reoviridae
provided the first RNA cap MTase structures at 3.6 A ˚ resolution
as forming part of the reovirus core[29]. Another RNA cap
machinery was more recently described for the non-turreted
orbivirus Bluetongue virus VP4 protein at 2.5 A ˚ resolution[30],
which revealed a three-domain protein, with a ‘‘head’’ guanylyl-
transferase domain, a central N7-guanine MTase, and a ‘‘bottom’’
29-O-MTase domain. This architecture illustrates the sequence of
three out of the four chemical reactions involved in RNA capping
described above.
Regarding (+)RNA viruses, MTase structural information at the
atomic level is only available for a single genus. The flavivirus N-
terminus domain (residues 1–265) of the NS5 RNA-dependent
RNA polymerase harbors an RrmJ fold with an N-terminus
extension able to accommodate RNA cap structures[31,32]. This
enzyme carries both N7-guanine MTase and 29-O-MTase
activities on a single domain with one shared active site[33].
Homologous domains have been crystallized for a number of
flaviviruses, revealing a conserved fold and activity[34], suggesting
that MTases might represent interesting targets for drug design.
No other (+)RNA virus RNA cap MTase crystal structures have as
yet been defined.
In 2003, the identification of the 29-O-MTase signature
sequence in the SARS-CoV genome added nsp16 to the list of
putative targets for antiviral drugs[35]. Several compounds have
been shown to inhibit viral MTases, such as the co-product of the
MTase reaction SAH, Sinefungin, and aurintricarboxylic acid
(ATA)[14,36,37,38,39]. In this paper, we report the crystal
structure of the SARS-CoV 29-O-MTase nsp16 in complex with
its activator, the zinc finger protein nsp10, at 2.0 A ˚ resolution, in
conjunction with mutagenesis experiments, binding and activity
assays. These results lay down the structural basis for the nsp10
function as an activator of nsp16-mediated 29-O-MTase. We
identify residues playing key roles in the nsp10/nsp16 interaction,
as well as other residues involved in 29-O-MTase catalysis and
RNA binding. We also report the crystal structure of the nsp10/
nsp16 complex bound to the inhibitor Sinefungin. Comparison
with known cellular SAM binding sites points to the nsp16
nucleobase binding pocket as a possible target for the design of
selective antiviral molecules.
Results
Crystallization and Structure Determination of an Active
nsp16 29-O-MTase
We observed that purified nsp16 was unstable in solution,
impeding crystallogenesis. Yeast double-hybrid and co-immuno-
precipitation experiments on purified SARS-CoV nsp10 and
nsp16 have uncovered the reciprocal interaction of these two
proteins[16,17,18]. Indeed, SARS-CoV nsp16 exhibits 29-O-
MTase activity only when complemented with SARS-CoV
nsp10, raising the interesting possibility that nsp10 acted as a
Author Summary
A novel coronavirus emerged in 2003 and was identified as
the etiological agent of the deadly disease called Severe
Acute Respiratory Syndrome. This coronavirus replicates
and transcribes its giant genome using sixteen non-
structural proteins (nsp1-16). Viral RNAs are capped to
ensure stability, efficient translation, and evading the
innate immunity system of the host cell. The nsp16 protein
is a RNA cap modifying enzyme only active in the presence
of its activating partner nsp10. We have crystallized the
nsp10/16 complex and report its crystal structure at atomic
resolution. Nsp10 binds to nsp16 through a ,930 A ˚2
activation surface area in nsp10, and the resulting complex
exhibits RNA cap (nucleoside-29-O)-methyltransferase ac-
tivity. We have performed mutational and functional
assays to identify key residues involved in catalysis and/
or in RNA binding, and in the association of nsp10 to
nsp16. We present two additional crystal structures, that of
the known inhibitor Sinefungin bound in the SAM binding
pocket, and that of a tighter complex made of the mutant
nsp10(Y96F) bound to nsp16. Our study provides a basis
for antiviral drug design as well as the first structural
insight into the regulation of RNA capping enzymes in
(+)RNA viruses.
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cistronic prokaryotic expression vector facilitated affinity chroma-
tography purification and crystallization of the complex[16,40].
Crystals diffracted to ,1.9 A ˚. The position of the nsp10 protein
was determined using molecular replacement with the SARS-CoV
nsp10 protein structure[20] as a search model. Strong peaks in
both the residual and anomalous Fourier maps confirmed the
presence of two zinc ions. Nsp16 was well defined by its electron
density except for two flexible loops (residues 19–35 and 135–137)
with high B factors and weak or missing electron density. These
loops are solvent-exposed at each side of the putative RNA-
binding groove (see below). Structure determination data and
refinement statistics are reported in Table 1.
Structure of the nsp10/16 Heterodimer
The heterodimer can be conveniently viewed as nsp16 sitting on
top of a nsp10 monomer (Fig. 1A). The nsp10 overall structure in
the complex remains essentially unchanged relative to published
structures of nsp10 alone, with its N-terminus comprising two a-
helices, a central b-sheet domain, and a C-terminus domain
containing various loops and helices (see[20,21], Fig. 1B).
Comparison with existing crystal structures of nsp10 using
DaliLite[41] rendered nsp10 atomic coordinates very similar to
those of nsp10 in our nsp10/nsp16 complex. The average RMSD
is about 0.77 A ˚ in 118 residues (PDB codes 2FYG, 2G9T and
2GA6[20,21]). This indicates that neither significant conforma-
tional change nor surface modification occurs in nsp10 when
binding to nsp16. The nsp10 structural Zn
2+ ions are not directly
involved in the nsp10/nsp16 interface (Fig. 1A).
Nsp16 adopts a canonical SAM-MT fold (Figs. 1B, 2A and B),
as defined initially for the catechol O-MTase[25]. The seven-
stranded b-sheet MTase fold has been described as having a
secondary structure topology defining two binding domains, one
for SAM and the other for the methyl acceptor substrate (Fig. 2A).
The nsp16 topology matches those of dengue virus NS5
N-terminal domain and of vaccinia virus VP39 MTases[27,31].
Nsp16 lacks several elements of the canonical MTase fold, such as
helices B and C (Fig. 2B).
S-adenosylhomocysteine- and Sinefungin-Binding
Electron density corresponding to one molecule of S-adeno-
sylhomocysteine (SAH), the co-product of the methylation
reaction, was identified in the putative SAM-binding site
(Figs. 1A and 3A). Neither SAM nor SAH was added to the
purification or crystallization buffers, therefore it must have been
captured from the medium by nsp16 during bacterial growth. The
SAH molecule is found with its adenine in an anti conformation
and the ribose pucker in a southern (29-endo/39-exo) conformation.
All the residues involved in SAM/SAH binding are absolutely
conserved in coronavirus np16s (Fig. S1). Binding specificity for
SAM/SAH is achieved by holding distal SAM/SAH carboxylic
and amino groups through five hydrogen bonds (G81, N43, Y47,
G71, and D130) (Fig. 3A and Fig. S2A). The ribose moiety is held
by three hydrogen bonds involving Y132, G73, and D99. As in the
case of other MTases[25], the SAH binding cleft is globally
positively charged. However, an aspartic acid (D99) acts as the
ribose-sensing residue with its side chain carboxyl making strong
hydrogen bonds with both ribose hydroxyls (Fig. S2A). Binding of
the adenine base involves few contacts. The nucleobase occupies a
loose hydrophobic pocket engaging two hydrogen bonds of
moderate strength with side chain and main chain atoms of
conserved residues D114 and C115, respectively.
Soaking the crystals into a Sinefungin-containing buffer
captured this MTase inhibitor in the SAH binding site almost
perfectly superimposable on SAH (Fig. 3B and Fig. S2B). Binding
involved the same residues and contacts as SAH. Inhibition of the
MTase reaction by Sinefungin therefore probably occurs compet-
itively. The Sinefungin amino group quasi-isosteric to the donated
SAM methyl group indicates a cavity where the 29-hydroxyl of the
capped RNA is expected to bind. Lining this empty substrate
Table 1. Crystal, collection, structure determination data and refinement statistics.
DATA wild-type (SAH) nsp10(Y96F)/nsp16 wild-type (SFG)
Instrument SOLEIL, Proxima I ESRF ID14-1 ESRF ID23-1
Wavelength 0.9792 0.9334 0.9792
Space group C2221 C2221 C2221
Cell dimensions a, b, c (A ˚) 68.07 184.62 128.83 68.15 184.80 129.01 68.42 185.04 129.46
Resolution range (A ˚) 37.52-2.00 (2.11 – 2.00)* 45.51-2.05 (2.17 – 2.05) 45.58 -2.50 (2.64 – 2.50)
Total number of reflections 201703 (29338) 187379 (27241) 211213 (30837)
Number of unique reflections 54947 (7963) 51033 (7362) 28921 (4163)
Completeness (%) 99.7 (100) 99.6 (100) 100 (100)
I/s(I) 7.1 (2.7) 7.5 (3.2) 12.5 (4.3)
Rsym ** 0.114 (0.430) 0.112 (0.350) 0.102 (0.400)
Multiplicity 3.7 (3.7) 3.7 (3.7) 7.3 (6.7)
Refinement (20 cycles)
R*** 0.213 0.200 0.201
Rfree 0.227 0.234 0.215
RMSD bond length (A ˚) 0.007 0.007 0.011
RMSD bond angle (A ˚) 1.015 0.968 1.250
*Values in parentheses give the high resolution shell values.
**Rsym =S |I-,I.|/S I.
***R=S||Fo|-|Fc||/S |Fo|.
doi:10.1371/journal.ppat.1002059.t001
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reaction: K46, D130, K170, and E203[16]. Alanine substitutions
in the catalytic tetrad (K46, D130, K170, or E203) almost
completely block 29-O-MTase activity without jeopardizing
binding to nsp10 (Table 2, and [16]). Several SAM-binding
residues (N43, G73, D99 and Y132, Fig. S2A) were substituted by
alanine. Although they conserve their specific nsp10 binding
properties, indicating that they are correctly folded, they all show a
drastically reduced MTase activity (Table 2), validating the
structural description of the nsp10/nsp16/SAH ternary complex.
AM g
2+ Cation is Present in nsp16, Outside the Active Site
We recently reported[16] that nsp10/nsp16 MTase activity
requires Mg
2+. Although the crystallization buffer contains Mg
2+,
we were unable to locate any such cation in the nsp16 active site.
In enzyme activity assays, the Mg
2+ ion can be substituted by
Mn
2+ or Ca
2+, but not Zn
2+ (data not shown, see also[16]). A peak
of electron density presumably corresponding to Mg
2+ is localized
onto nsp16, distant from the SAH-binding cavity. The Mg
2+
coordination mode is through six first-shell water molecules in an
octahedral geometry (Fig. 4). Binding via water molecules, involves
T58 and S188 side chain hydroxyls and the main chain carbonyl
of E276. Since there are no carboxylic acids involved in binding
this cation, it was suspected that its presence resulted from the
crystallization procedure[42], with no biological relevance.
However, the T58A, T58N, T58E and S188A substitutions show
43, 70, 99 and 72% loss of activity, respectively (Table 2), with no
significant effect on the stability of the nsp10/nsp16 complex
except for T58E whose association was 54 % that of wild-type.
These residues are located on three distinct structural elements at
the C-terminus of helix Z (T58), the N-terminus of b6 (S188), and
in the central part of helix A3 (E276), respectively (Fig. 4 and Fig.
S3). The cation may thus hold these elements together.
The Putative RNA Binding Site: Mutagenesis and Effect
on Activity
The nsp10/nsp16 complex absolutely requires an N7-methyl
guanine capped RNA substrate to exhibit MTase activity[16]. The
structural basis for the preferential binding to methylated N7-
guanine versus non-methylated caps has been elucidated in four
cases, those of VP39[27], eIF4E[43], CBC[44], and PB2[45]
proteins (PDB codes 1AV6, 1EJ1, 1H2T, and 2VQZ, respectively)
Figure 1. Cartoon representation of the nsp10/nsp16 complex with the reaction product SAH and metal ions. A) The nsp16 protein
(green) is bound to nsp10 (yellow) through an interface which does not involve Zn ions (grey spheres) present in nsp10. One metal ion (blue sphere)
is found in nsp16 on the opposite face from the active site to which a SAH molecule is found (red sticks). B) Ribbon representation of nsp16, rainbow
colors from N- to C-terminus. Top: Each secondary structure element is labeled according to[25] (see also Fig. S3). The SAH molecule shown in sticks
colored following atom type. Bottom: View of interface involving nsp16 (green surface) and nsp10 (yellow ribbons) showing the nsp10 secondary
structure elements involved in the interface.
doi:10.1371/journal.ppat.1002059.g001
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methylated base specificity is achieved through increased
binding energy resulting from the stacking of the N7-methyl
guanine between parallel aromatic residues of the cap binding
protein. The presence of the methyl group greatly enhances p-p
stacking, providing a dominant effect over unmethylated
guanine[46]. Despite numerous attempts, cap analogues
(m7GpppA, GpppA, m7GpppG, GpppG) and short capped
RNA substrates (m7GpppA(C)n) could neither be co-crystallized
with nsp10/nsp16 nor soaked and bound onto preformed
nsp10/nsp16 crystals. However, the atomic coordinates of the
N7-methyl guanine RNA oligomer in complex with VP39[47]
provided data from which a model of RNA binding to the nsp16
protein was derived. SAM molecules identified in both
structures were superimposed, and the VP39-bound RNA was
positioned onto the nsp16 structure. After minimal manual
adjustments not exceeding 5 A ˚, the VP39 RNA was a
reasonably good fit into an nsp16 hydrophobic groove radiating
from the catalytic site (Fig. 5), establishing very few contacts
with nsp10. We note that the protein side diametrically opposite
Figure 2. Topology diagram of MTase secondary structure elements. A) The consensus topology diagram is shown with a two domain
organization for methyl acceptor substrate and SAM, as defined[25] with the catechol O-MTase and its canonical seven strand beta sheet. B) Topology
diagram of nsp16 colored according to rainbow colors from N-to C-terminus as in Fig. 1B. The missing helix B and helix C are indicated by dashed
ovals. The approximate general binding site of nsp10 is shown (yellow oval).
doi:10.1371/journal.ppat.1002059.g002
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positively charged (not shown), an observation that may account
for the difficulty of achieving experimental RNA binding in the
proposed RNA binding site. In the absence of robust data to
guide docking of the guanine cap, the m7Gpp cap structure was
not positioned in the structure but two possible N7-methylated
cap guanine binding areas are indicated by arrows (Fig. 5). The
first transcribed nucleotide together with its ribose receiving the
methyl group fit well in the active site (Fig. 5, panel B) as
predicted in the proposed mechanism. The same holds for the
immediately preceding three nucleotides. The base of the first
transcribed nucleotide may be held by contact with P134 and
Y132, bending the extending RNA cap structure. Accordingly,
the substitution of Y132 greatly depresses MTase activity
(Table 2). We also note that Y132 is located in the vicinity of
a highly mobile loop (residues 135-138) not always visible in our
crystal structures suggesting that this loop may move in order to
wrap the triphosphate moiety of the RNA cap and/or the RNA
cap itself. The solvent exposed side chain of Y30 may also
participate in RNA binding. In the model, the highly mobile
side chain of Y30 was flipped out in an alternative conformation
in order to open the groove. In that position, Y30 should
specifically contact the third transcribed nucleotide. Our
m u t a g e n e s i sd a t ac o n f i r m st h eimportance of Y30 since its
replacement with either Ala or Phe severely impairs MTase
activity without affecting the interaction with nsp10 (Table 2).
Interface of the Heterodimer
All nsp10 secondary structure elements but helices 2 and 5
contact nsp16 (Fig. 1). The nsp10 contact points can be viewed as
5 small patches A to E (residues 40–47, 57–59, 69–72, 77–80, and
93–96, respectively, Fig. 6A). In turn, these five patches contact
most of the nsp16 SAM-binding structural elements in 4 areas, I to
IV (Fig. 6B, Fig. S3)), mainly involving b2, b3, aA, aZ, and for
area IV, the loop connecting helices A2 and A3 at the C-terminus
(Figs. 1 and 6). In total, the interface of the heterodimer involves
53 residues, 23 and 30 from nsp10 and nsp16, respectively. In
nsp10, a single residue (Asn10, at the edge of the interaction
surface) is not conserved out of 23 (4.3 %), whereas in nsp16 there
are 8 non-conserved residues out of 30 (26.7 %) (Fig. S1). The
interface has a buried surface area of 1820 A ˚ 2, with nsp10
contributing to 930 A ˚ 2 and nsp16 to 890 A ˚ 2.
Four nsp10 patches included in the 5 interaction patches
identified here were recently mapped using reverse yeast two-
hybrid methods coupled to bioluminescence resonance energy
transfer and in vitro pull-down assays (see[18] and below). To probe
the observed crystal structure of the interface further, we
engineered 5 new nsp10 alanine mutants (N40A, L45A, T58A,
G69A, and H80A, see Table S1) sitting in patches A, B, C and D.
Whereas T58A, G69A and H80A showed limited effect on nsp16
binding, N40A reduced it to 64% of wild type affinity, and L45A
almost abrogated it. The crystal structure indicates that the nsp10
interface proposed by Lugari et al.[18], is a correct and
conservative estimation, as the interface also includes L45
belonging to patch A. We also confirm the positive co-relation
of the detected nsp10/nsp16 interaction with MTase activity. In
no instance can nsp16 be active in the absence of nsp10/16
complex formation.
The Y96 position is of particular interest. Alanine substitution
(Y96A) abrogates interaction whereas a phenylalanine (Y96F)
increases both interaction and MTase activity[18]. In order to
understand how residue 96 plays such a pivotal role, we
determined at 2.0 A ˚ resolution the crystal structure of this
nsp10(Y96F)/nsp16 complex (Table 1). Strikingly, the absence of
the hydroxyl group does not alter the topology of the interface.
Wild-type and Y96F residues superimpose without significant
difference at all atomic positions (not shown). Either Y96 or F96 is
in direct contact with nsp16 helix aZ, which carries the catalytic
residue K46. Detailed surface analysis using PISA indicates that
the position of K46 in Y96F nsp10 is identical to that of K46 in
wild-type nsp10, ruling out a better alignment of catalytic residues
of the Y96F mutant. The nsp10(Y96F)/nsp16 differs from wild-
type nsp10/nsp16 in the SAH binding site, though. When
compared to that of wild-type, the SAH occupancy is much lower
Figure 3. The SAM binding site of nsp16. A) SAH modeled in a simulated annealing Omit map contoured at 1s. Carbons, oxygens, sulfur, and
nitrogens are in grey, red, yellow, and blue sticks, respectively. Water molecules are shown as red spheres. B) Sinefungin bound in the SAM/SAH
binding site, with main catalytic residues and the water molecule indicative of a catalytic mechanism. Colors as in A). C) SAH modeled in a 2Fo-Fc map
(green) of Sinefungin contoured at 1s with a Fo-Fc difference map (red) contoured at 3s. A peak of negative density appears clearly on the sulfur
atom of the SAH molecule showing that SAH was indeed replaced by Sinefungin. Colors as in A).
doi:10.1371/journal.ppat.1002059.g003
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known to be a fairly good inhibitor of the methylation reaction.
Therefore, a lower binding affinity might translate into less end-
product inhibition, and account for the observed increased
activity. We measured the affinity of nsp16 for SAH using
fluorescence spectroscopy, but no significant differences were
found (not shown). Likewise, the MTase inhibition pattern by
SAH was identical for wild-type and nsp10(Y96F)/nsp16 (not
shown). We therefore infer that the previously observed ,10-fold
increased stability of the heterodimer[18] may be responsible for
the increased activity. A more hydrophobic character of the
interaction may appear upon the loss of the tyrosine hydroxyl
which, in the wild-type protein, was not engaged in any polar
contact. We thus attribute the increased activity of the
nsp10(Y96F)/nsp16 complex relative to wild-type to a stronger
equilibrium association of nsp10(Y96F) with nsp16 than that of
wild-type nsp10 with nsp16.
Mutation analysis was also conducted on nsp16 residues
presumably involved in the interface and interfacial activation
(Tables 2 and S2). Several mutants (V78A, V104A, L244A,
M247A) in patches II, III and IV completely disrupt the nsp10/
nsp16 complex and annihilate nsp16 MTase activity. Interestingly,
we also identified nsp16 mutants still interacting with nsp10, but
with a strongly reduced 29-O-MTase activity (I40A, M41A, V44A,
T48A, Q87A, D106A) suggesting, that these mutations in the
nsp10/nsp16 interface may alter the fine positioning of catalytic
residues without any significant effect on nsp10 binding.
Accordingly, most of these mutants are localized in aZ helix of
Table 2. Mutational analysis, complex formation, and enzyme activity of the nsp10/nsp16 complex.
Number Function* Mutant % associated** % MTase act. ***
1= Wild-Type Wild-TypE Wild-Type 100 100
2 Catalytic K46A 97 1
3 Catalytic D130A 104 2
4 Catalytic K170A 95 0
5 Catalytic E203A 93 0
6 SAM-BS N43A 144 11
7 SAM-BS G73A 119 18
8 SAM-BS D99A 57 0
9M g
2+-BS T58A 123 57
10 Mg
2+-BS T58N 110 30
11 Mg
2+-BS T58E 54 1
12 Mg
2+-BS S188A 102 28
13 RNA/SAM-BS Y132A 86 5
14 RNA/SAM-BS Y132T 95 5
15 RNA/SAM-BS Y132F 123 9
16 RNA/SAM-BS Y132H 106 0
17 RNA-BS Y30A 89 1
18 RNA-BS Y30F 113 6
Interface mutants
Number Location* Mutant % associated** % MTase act. ***
19 Patch I I40A 84 8
20 Patch I M41A 122 4
21 Patch I V44A 113 1
22 Patch I T48A 123 20
23 Patch II V78A 3 0
24 Patch II R86A 61 0
25 Patch II Q87A 114 62
26 Patch III V104G 6 4
27 Patch III D106A 101 38
28 Patch IV L244A 30 0
29 Patch IV M247A 4 0
*as inferred from the crystal structure.
**nsp10/nsp16 complex formation as determined using pull-down experiments, SDS-PAGE analysis, and quantitation (see Methods).
***The % of MTase activity was determined using filter binding assays (see Methods) relative to wild-type.
SAM-BS: S-adenosylmethionine binding site.
Mg
2+-BS: Magnesium binding site.
RNA-BS: RNA binding site.
doi:10.1371/journal.ppat.1002059.t002
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hand, patch II and III mutants tend to have more mitigated
phenotypes, yielding to full-blown interaction with only about half
of the expected activity. Finally, patch IV mutants were totally
inactive. Using all mutants reported in Table 2, a plot (Fig. 6C) of
interaction versus activity shows that the nsp10/nsp16 interaction
is strictly required to obtain significant nsp16 MTase activity.
Discussion
Mechanism of 29-O-Methyltransfer
The SARS-CoV RNA cap 29-O-MTase is a heterodimer
comprising SARS-CoV nsp10 and nsp16. When bound to nsp10,
nsp16 is active as a type-0 RNA cap-dependent 29-O-MTase, ie.,
active only when the cap guanine is methylated at its N7
position[16]. The nsp10/nsp16 crystal structure shows that nsp16
adopts a typical fold of the S-adenosylmethionine-dependent
methyltransferase family as defined initially for the catechol O-
MTase[25]. A good alignment (170u) is found between the SAH
sulfur atom, a water molecule present in both SAH- and sinefungin-
bound nsp16 structures, and the K46 e-amino group (Fig. 3A and
B). This geometry provides interesting hints for a catalytic
mechanism, as the positions of the catalytic residues (K46, D130,
K170, E203) match spatially those of the vaccinia virus VP39 29-O-
MTase[47]. At the initialstage of the reactionthe 29-hydroxyl of the
capped RNA substrate would occupy the position of the water
molecule. In turn, E203 and K170 decrease the pKa of the K46 e-
amino group that becomes a deprotonated general base (-NH2)a b l e
to activate the RNA 29-hydroxyl at neutral pH. In VP39, K175 has
been identified as the general base catalyst[47] with a pKa
depressed by , 2 pH units by the neighbouring D138 and R209
residues[48]. These findings indeed suggest a related mechanism:
once K46 has activated the 29-hydroxyl group, the 29-oxygen would
produce an in line attack through a SN2-like mechanism onto the
electrophilic SAM methyl group. The methyl group would pass
through a pentavalent intermediate with the 29-O and sulfur at
apical positions. D130 is positioned to stabilize the transient positive
charge on the donated methyl atom of SAM before the sulfur
recovers a neutral electric charge during SAH generation (Fig. 3B).
Role of Mg
2+ on MTase Activity
Unlike most SAM-dependent MTases, the SARS-CoV nsp10/
nsp16 enzyme requires a divalent cation, either magnesium,
manganese or calcium[25]. We have found that this cation does
Figure 4. Position and coordination of a metal ion. Left, the putative Mg
2+ ion (blue sphere) is shown solvated in its first atomic shell by six
water molecules (red spheres). The corresponding 2Fo-Fc electron density map (contoured 1s) with a cross shape is shown in purple. Residues of
Nsp16 involved in coordination of Mg
2+ ion via water molecules are labeled. Right, a global view of the bound metal ion in its electron density on the
opposite side from the SAH molecule (red sticks). Nsp16 is shown as green ribbons, nsp10 as yellow ribbons with its two bound Zn
2+ as grey spheres
as in Fig. 1.
doi:10.1371/journal.ppat.1002059.g004
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through water molecules by three residues located on three distinct
structural elements. It is thus possible that one divalent cation,
presumably Mg
2+, present in the host cell at millimolar levels,
plays a structural role in holding these three nsp16 structural
elements together and so regulate the enzyme activity. It is
intriguing that T58A is more active than T58N or T58E that can
still bind the water that chelates to the metal. Alternatively, it is
possible that divalent cations such as Mg
2+ or Ca
2+ act as a
phosphodiester charge shield to allow RNA binding in the
hydrophobic binding groove[49].
MTase Activity is Regulated via Protein-Protein
Interactions
The main regulation mechanism of nsp16 is through its physical
association with nsp10. Nsp16 is unstable in solution, and nsp10
acts as a scaffold for nsp16, yielding a stable dimer active as an
RNA cap-dependent (nucleoside-29-O)-MTase. The complex is
assembled through a ,890 A ˚ 2 contact surface in nsp16, an area
typically in the intermediate zone differentiating strongly from
weakly associated dimers[50]. This finding is consistent with a Kd
estimated at ,0.8 mM[18] that qualifies the nsp10/nsp16 complex
as a rather weak heterodimer. The nsp10 interaction surface
identified in the crystal structure was confirmed by site-directed
mutagenesis and overlaps that previously identified by indirect
methods[18]. Remarkably, the nsp10 surface in the nsp10/nsp16
complex is essentially identical to that of uncomplexed nsp10
crystallized alone by others[20,21](Fig. S4). It is therefore
reasonable to see this heterodimer as a non-permanent species
which would tolerate nsp10 or nsp16 engaging in interactions with
other partners. This notion is actually in line with the involvement
of nsp10 in a network of protein-protein interactions that we and
others have proposed[17,19]. Donaldson et al.[23] have engi-
neered mutations in nsp10 using reverse genetics. Out of eight
mutations that turned out to be in the nsp10/nsp16 interface (this
work), five, two and one rendered lethal, debilitated, and viable
phenotypes, respectively[23]. Interestingly, the nsp10(Q65E)
mutant providing a temperature-sensitive phenotype[22,23] does
not map in the nsp10/nsp16 interface, confirming that nsp10 has
a pleı ¨otropic role.
Our mutagenesis analysis shows that the formation of an nsp10/
nsp16 complex is a pre-requisite for MTase activity (Fig. 6C)
indicating that physical association of nsp10 and nsp16 is essential
to activate nsp16 29-O-MTase activity and foster efficient virus
Figure 5. Stick model of RNA bound to the nsp16 RNA binding groove and Sinefungin in the methyltransferase active site. A) In this
representation, Sinefungin was preferred over SAH because one of its NH2 groups approximates the direction of a transferred CH3 group from the
SAM substrate. Carbon is white, oxygen is red, nitrogen is blue and phosphorous is orange. Nsp16 and nsp10 are rendered as a solvent-accessible
surface colored grey and wheat respectively. The Sinefungin molecule defines the methyltransferase active site. Missing residues in the 135-137 loop
(see text) are indicated by a shaded blue dotted box. Position of Y30 and Y132 are indicated. Y30 generated poor electron density (see « Methods »)
and its aromatic ring position has been manually adjusted before generation of this image. B) Close caption of the methyltransferase active site
showing distance between the NH2 of Sinefungin to the 29-O of the ribose of the first base, thus mimicking the position of the methyl of the S-
adenosylmethionine.
doi:10.1371/journal.ppat.1002059.g005
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loss of their 29-O-MTase activity, whereas the apparent associa-
tion affinity is often only modestly affected. That minor changes in
the interface translate into potent effects is also dramatically
illustrated by the Y96F mutation, where the loss of a single
hydroxyl provokes a significant change in affinity[18]. Remark-
ably, it is not the most active complex that was selected in nature,
since the nsp10(Y96F)/nsp16 complex is both more stable and
more active than the wild-type heterodimer (this work and[18]).
This is yet another observation hinting at the involvement of nsp10
in protein-protein interaction networks including other partners
than nsp16, such as nsp5 and nsp14[17,19]. In most other
coronaviruses, the nsp10 residue at position 96 is a phenylalanine.
It would be interesting to determine whether this polymorphism is
relevant to the SARS-CoV pathogenicity at any (direct or indirect)
level, or if compensating polymorphisms in other coronaviral
nsp10 (or nsp16) restore a weaker nsp10/nsp16 association
equivalent to that of the SARS-CoV pair. Since a bona fide viral
RNA cap is key in evading the host cell innate immunity[4,51], a
minimal level of 29-O-MTase activity would be expected to be
critical to virus survival.
MTase activation through dimerisation of two viral protein
partners has already been reported in the case of the vaccinia virus
D1/D12 N7-guanine MTase[28]. However, the activating D12
subunit does not contact the D1 subunit through a homologous
surface mainly defined by canonical aA and aZ helices. Rather,
the D1/D12 activation surface would be located at a 90u clockwise
rotation relative to the nsp10/nsp16 interface depicted in Fig. 1A.
In the case of dengue virus, the bi-functional N7-guanine and 29-
O-MTase is part of the N-terminus of the dengue NS5 protein.
Based on reverse genetic data and modeling[52], the MTase
domain would be associated with the Pol domain through an
interface topologically similar to that of nsp10/nsp16, i.e.,
involving mainly helices aA, aZ and strands b2 and b3a s
depicted in Fig. 1A.
We have previously shown that the nsp10/nsp16 is only active
as N7-guanine methylated capped RNA, implying that RNA cap
methylation obeys to an ordered sequence of events where nsp14-
mediated N7-guanine methylation precedes nsp10/nsp16 RNA
29-O methylation[16]. In the absence of data regarding the RNA
substrate, we built a model of RNA binding based on that of the
vaccinia virus VP39 ternary complex structure. Interestingly, our
model proposes that the RNA interacts only with nsp16 residues,
in keeping with what was recently suggested based on RNA
binding assays[14]. Although the position of the cap structure on
the nsp16 surface remains to be determined, our model suggests a
well-defined position for the ribose of the first transcribed
nucleotide in the active site. In agreement with mutagenesis
analysis, the model also suggests that the transcribed RNA 59-end
stacks between Y132 and Y30. Furthermore, this model is
consistent with the observation that coronavirus MTase requires
RNA substrates of at least 3 transcribed nucleotides in length[14].
It is also worth to know that a comparison of nsp16 and VP39
electrostatic surfaces reveals that the putative RNA-binding groove
of nsp16 is mostly hydrophobic, whereas the VP39 RNA-binding
groove is positively charged. This variation would imply a change
in the nature of the RNA/protein interaction.
Binding of Sinefungin to nsp16/nsp10 Suggests
Feasibility of a Drug Design Approach to Inhibit MTase
Activity
Viral MTases are increasingly evaluated as potential drug
design targets[34,37,53]. We have crystallized the inhibitor
Sinefungin with the nsp10/nsp16 complex. Sinefungin exhibits
an IC50 of 0.74 mM, 16-fold lower than that of SAH as reported by
Bouvet et al.[16] using purified nsp10/nsp16. Analysis of the
structure suggests a likely mechanism of action that also accounts
for the observed inhibitory effect of this drug. We note that the
adenine nucleobase does not fit snugly into its binding pocket,
raising interest regarding structure-based drug design. Preliminary
examination of eukaryotic non-viral MTase structures from main
classes as defined in Martin and McMillan[25] indicates that the
SAH adenine is bound tighter in any of the latter enzymes than in
the nsp16 SAM-binding site, indicating a possible breach to
achieve anti-coronavirus selectivity with a small molecule inhibitor
of nsp16.
In conclusion, the crystal structures presented here extend our
general understanding of the mechanism and regulation of viral
RNA cap MTases in (+)RNA viruses, and point to both the nsp10/
nsp16 interface and the substrate binding sites as putative antiviral
targets.
Methods
Crystallization and Data Collection
Both nsp10 and nsp16 were expressed from the same dual
expression vector pmCOX [16]. Nsp10 had a N-terminal strep-tag
(WSHPQFEK), and nsp16 a N-terminal hexa-histidine tag. The
purification and crystallogenesis of the nsp10/nsp16 complex was
performed as described in [40]. Typical crystals of the wild-type
nsp10/nsp16 appear in hanging drops after 24 h at 20uC in 0.1 M
CHES pH 9, 1.52 M MgCl2 hexahydrate. Crystals (a=68.53 A ˚,
b=184.74 A ˚, c=129.01 A ˚, C2221) contain one nsp10/nsp16
complex per asymmetric unit, with a solvent content of 70 % and
Vm of 4.17 A ˚ 3/Da. Crystals of nsp10(Y96F)/nsp16 were grown in
67 mM CHES pH 8.5, 0.99 M MgCl2 hexahydrate, 33 mM Tris-
HCl, 8.3 % PEG 8000. Both crystallization conditions yielded
crystals diffracting to 1.9 A ˚ when exposed to synchroton radiation
at the ID14-1 beamline of the European Synchrotron Radiation
Facility, Grenoble, France. Crystals were cryo-cooled in the same
buffer supplemented with 15 % glycerol. Crystal soaking was
performed in the same buffer supplemented with 5 mM SAH or
Sinefungin during 24 h.
Structure Determination and Refinement
The position of the nsp10 protein was unambiguously
determined by molecular replacement using the program
PHASER[54] with the nsp10 protein (2FYG), as search probe[20].
Strong peaks in both the residual and anomalous Fourier maps
confirmed the presence of two Zinc ions at the expected positions
within the nsp10 protein, thus giving confidence in the validity of
the MR solution. Phases calculated from this partial model were
combined with SAD phases from the Zn atoms using PHASER.
To ameliorate the resulting low quality density map, phases were
improved with PARROT[55]. An initial model, comprising both
Figure 6. Detailed definition of nsp16 and nsp10 elements involved in the interface. A) nsp16 (left) and nsp10 (right) are rendered as a
solvent-accessible surface colored green and yellow, respectively. Residues involved in the interface are rendered as sticks with the same color code,
in transparency into respective proteins. B) Separate representation of the nsp16 (left) and nsp10 (right) interface. Nsp16 residues defining patch I, II,
III, and IV are rendered as sticks as above in transparency into nsp16. Nsp10 residues defining patch A, B, C, D, and E are rendered as sticks as above in
transparency into nsp10. C) A plot of MTase activity as a function of nsp10/nsp16 complex formation using the data reported in Table 2.
doi:10.1371/journal.ppat.1002059.g006
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BUCCANEER[56] and ARP/wARP[57]. The resulting model
was subject to several cycles of manual rebuilding using COOT
[58] and refinement with REFMAC [59]. The protein structure
model could be built, except the strep and hexahistidine tags. In
nsp16, density was too weak for the mobile, solvent exposed nsp16
loop 136–139, Y30 (see ‘‘Results’’), and 2 and 6 residues in N- and
C-terminus, respectively. Likewise, nsp10 solvent exposed 9 and 8
residues in N- and C-terminus were missing, respectively.
Overall, the chain traces are unambiguous, with clear electron
density including for a single SAH residue bound to the nsp16
protein. Solvent accessible surfaces were calculated using program
AREAIMOL [60] with a 1.7 A ˚ radius sphere as the probe
(Table 1) and values rounded to the nearest 5 A ˚ 2. Conformational
differences were analyzed using the DynDom server (http://www.
cmp.uea.ac.uk/dyndom/main.jsp). Figures were created using
PYMOL (http://www.pymol.org). The coordinates of the wild-
type/SAH, mutant, and wild-type/Sinefungin structures have
been deposited at the Protein Data bank under PDB codes 2XYQ,
2XYV, and 2XYR, respectively.
RNA Cap Structure Modeling
The modeling of the RNA cap structure in the nsp10/nsp16
complex structure is derived from the analysis of the structure of
the vaccinia virus methyltransferase VP39 crystallized in complex
with a capped RNA and a S-Adenosylhomocysteine[47] (SAH)
(pdb code: 1AV6). The two structures are manually aligned using
COOT[58] based on the position of SAH binding sites, as well as
SAH, and Sinefungin (SFG) molecules. The RNA binding site of
VP39 is only partly overlapping that of nsp16 whilst the shape of
the cavity is similar; thus local adjustments necessary to
accommodate the RNA molecule in its binding groove were done
manually using COOT. The side chain of tyrosine 30 of
nsp16initially pointed to the putative RNA binding site, preventing
any bona fide modeling. In order to fit the RNA molecule in the
cavity, an alternative conformation was sought for this side chain.
The second most common conformation for the tyrosine side
chain was selected. Due to the biochemistry data and surface
electrostatic analysis, it is not possible to describe with certainty the
final position of the cap, thus the cap was removed and replaced
by arrows symbolizing possible positions. No other modification
was performed on the RNA, the Sinefungin molecule or the nsp16
structure.
Plasmids
The SARS-CoV nsp10 and nsp16-coding sequences were
amplified by RT-PCR from the genome of SARS-CoV Frank-
furt-1 (accession number AY291315) as previously described[16].
The nsp10 and nsp16 genes (encoding residues 4231–4369, 5903–
6429, and 6776–7073 of replicase pp1ab) were cloned into a
Gateway modified dual-promotor expression plasmid and in the
gateway pDest 14 expression vector. In this backbone, SARS CoV
nsp10 can be expressed under a tet promoter and encodes a
protein in fusion with a N-terminal strep tag, whereas nsp16 is
expressed under a T7 promoter and encodes a protein in fusion
with a N-terminal hexahistidine tag. The mutants were generated
by PCR using the Quickchange site–directed mutagenesis kit
(Stratagene), according to the manufacturer’s instructions.
Reagents
AdoMet and cap analogs GpppA and
7MeGpppA were
purchased from New England BioLabs, the[
3H]-AdoMet was
purchased from Perkin Elmer and Sinefungin (adenosylornithine)
from Sigma-Aldrich.
Expression and Purification of SARS-CoV nsp10, nsp16
and nsp10/nsp16 Complex
E. coli C41 (DE3) cells (Avidis SA, France), containing the pLysS
plasmid (Novagen), were transformed with nsp10 or nsp16 cloned
in pDest14, or nsp10/nsp16 cloned in pmCox, and grown in 2YT
medium supplemented with appropriate antibiotics. The expres-
sion of strep-tagged nsp10 or 6His-tagged nsp16 mutants was
induced (DO600=0.6) by adding 50 mM IPTG, and the expression
of the nsp10/nsp16 complex by adding 50 mM IPTG and 200 mg/
L of anhydrotetracycline. After an incubation for a 16 h at 24uC,
the cell were pellets, frozen and resuspended in lysis buffer
(50 mM HEPES, pH 7.5, 300 mM NaCl, 5 mM MgSO4,5m M
b-mercaptoethanol (only for nsp10) supplemented with 1 mM
PMSF, 40 mM imidazole, 10 mg/ml DNase I, and 0.5% Triton
X-100. After sonication and clarification, proteins were purified
either by IMAC (HisPurTM Cobalt Resin; Thermo Scientific)
chromatography[16] (nsp10 mutants and nsp16 mutants), and the
nsp10/nsp16 complex was purified by using Strep-Tactin
sepharose (IBA Biotagnology) as previously described[16]. All
purified proteins were analyzed by SDS-PAGE. The binding of
wild-type nsp10 to mutant nsp16, and that of mutant nsp10 to
wild-type nsp16 was quantified using ImageJ as described[16].
Radioactive Methyltransferase Assay
MTase activity assays were performed in 40 mM Tris-HCl,
pH 8.0, 5 mM DTT, 1 mM MgCl2,2 mM
7MeGpppAC5 or
GpppAC5,1 0mM AdoMet, and 0.03 mCi/ml[
3H]AdoMet (GE
Healthcare). Short capped RNAs (
7MeGpppAC5, GpppAC5, were
synthesized in vitro using bacteriophage T7 DNA primase and were
purified by high-performance liquid chromatography (HPLC) as
previously described[61]. In the standard assay, nsp10 and nsp16
were added at final concentrations of 600 nM, and 200 nM,
respectively, and the amount of
3H-CH3 transferred onto
7MeGpppAC5 substrates was determined by filter binding assay
as previously described[16].
Supporting Information
Figure S1 Sequence alignment and amino acid conservation in
coronavirus nsp16. The alignment of coronavirus nsp16 sequences
wasgeneratedwith Muscle program (http://www.ebi.ac.uk/Tools/
msa/muscle/), and the resulting alignment converted using the
ESPript program, (http://espript.ibcp.fr/ESPript/cgi-bin/ESPript.
cgi). Residues that are conserved in all or .70% sequences are
boxed in red and yellow, respectively. National Center for
Biotechnology Information (NCBI) accession numbers for replicase
polyprotein sequences that include nsp16 are as follows: Severe
acute respiratory syndrome virus SARS-CoV Frankfurt isolate
(SARF), Severe acute respiratory syndrome virus SARS-CoV Tor2
isolate (SART), NP_828873.2; Turkey coronavirus (Turk),
YP_001941189; Infectious Bronchitis Virus (IBV), NP_066134;
Feline Coronavirus (Feli), YP_239426;Porcine Transmissible Gas-
troenteritis Coronavirus (PTGC), P18457; Transmissible Gastro-
enteritis coronavirus (TGEV), NP_840013; Porcine epidemic
diarrhea virus CV777 (PEDV), NP_839969; Bat coronavirus
512/2005 (BATC), YP_001351683; Human coronavirus NL63
(NL63), AAS58176; Human coronavirus 229E (229E), NP_073549;
Murine hepatitis virus strain JHM (MurJ), YP_209243; Mouse
Hepatitis virus strain A59 (MA59), NP_740613; Human coronavi-
rus HKU1 genotype A (HKU1), YP_460023; Human enteric
coronavirus 4408 (4408), ACJ35483; Bovine coronavirus (BCoV),
NP_742142; Human coronavirus OC43 (OC43), AAT84359.
Numbering was made using SARF as a reference.
(TIF)
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binding site. A) LIGPLOT diagram (www.ebi.ac.uk/thornton-srv/
software/LIGPLOT/) of the SAH ligand molecule interacting
with the nsp16 binding site. Ligand bonds are in purple, neighbor
residue (non-ligand) bonds are in light brown, hydrogen bonds are
green dashed lines. Ligand atoms surrounded by a yellow circle
are highly accessible. Non-ligand residues in hydrophobic contacts
with the ligand are presented by red semi-circles with radiating
spokes. B) Superimposition of SAH and Sinefungin molecules. The
nsp16 residues are green sticks, the SAH is represented in red
sticks, and Sinefungin and water molecules are in sticks and
spheres as in Fig. 3, respectively.
(TIF)
Figure S3 Primary and secondary structure elements of nsp16.
Helices and sheets are colored according to rainbow colors from
N- to C-terminus as in Fig. 1. Patches I to IV are boxed in grey,
labeled above the sequences, and correspond to residues
represented in Figs. 6A and B.
(TIF)
Figure S4 Nsp10 interface comparison between the nsp10/
nsp16 complex and nsp10 homo multimer. A) For the corre-
sponding nsp10/nsp16 interface nsp10 (cyan) interacts with 2
monomers (green and orange). Left: Cartoon representation of 3
nsp10 monomer part of the dodecamer structure (PDB: 2G9T).
Right: Cartoon representation of the nsp10(cyan)-nsp16(dark red)
complex. Nsp10 molecules in cyan are in the same orientation. B)
Nsp10 sequence is presented with above the corresponding
secondary structure elements. Below dark red colored dots indicate
residues involved in the interaction between nsp10 and nsp16
while green and orange dots indicate residues involved in the
homomultimer in the dodecamer complex.
(TIF)
Table S1 Effect of alanine mutations in nsp10 interface residues.
Residues were identified using PISA (http://www.ebi.ac.uk/
msd-srv/prot_int/pi_link.html). Bold on grey background: strictly
conserved residues amongst coronaviruses; Bold on white back-
ground: conserved a.a. (.70%) amongst coronaviruses (see Fig. S1).
The % of Bioluminescence Resonance energy Transfer (BRET)
signalwaspreviouslyreported[18].Theinteraction ofeachnsp10or
nsp16 mutant was determined using strep-tactin pull-down
experiments of strep-tagged nsp10 co-expressed with nsp16
followed by SDS-PAGE analysis, and quantitation (see Methods).
The interaction of wild-type nsp10 with wild-type nsp16 was
normalized to 100%. The % of MTase activity was determined
using filter binding assays (see Methods) relative to wild-type.
(DOC)
Table S2 Effect of alanine mutations in nsp16 interface
residues. Residues were identified using PISA (http://www.ebi.
ac.uk/msd-srv/prot_int/pi_link.html). Same legend as Table S1
except that no BRET experiments were performed.
(DOC)
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